Overview

The Efficacy and Safety of the Postoperative Adjuvant Treatment in Patients With High-risk Stage I Endometrial Carcinoma

Status:
Unknown status

Trial end date:
2020-12-01

Target enrollment:

Participant gender:

Summary

This randomized trial is studying the efficacy and safety of the chemotherapy compared with radiation therapy alone as adjuvant treatment after operation in Patients with high risk and Stage I endometrial carcinoma.

Phase:

Phase 3

Details

Lead Sponsor:

Ding Ma

Collaborators:

Huazhong University of Science and Technology
Shandong University
Zhejiang University

Treatments:

Carboplatin
Paclitaxel